FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.060
-0.090 (-7.83%)
At close: Aug 14, 2026, 4:00 PM EDT
1.100
+0.040 (3.77%)
After-hours: Aug 14, 2026, 7:34 PM EDT
FibroBiologics Employees
FibroBiologics had 15 employees as of December 31, 2025. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
n/a
Profits / Employee
-$1,209,267
Market Cap
7.06M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 13 | 3 | 30.00% |
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Sep 30, 2023 | 8 | 1 | 14.29% |
| Jun 30, 2023 | 7 | - | - |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AIM ImmunoTech | 21 |
| Processa Pharmaceuticals | 12 |
| CNS Pharmaceuticals | 8 |
| AEON Biopharma | 8 |
| MetaVia | 8 |
| Alzamend Neuro | 6 |
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 5 |
FBLG News
- 4 days ago - FibroBiologics awarded new patent from USPTO - TheFly
- 4 days ago - FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets - PRNewsWire
- 10 days ago - FibroBiologics announces EPO granted patent for gene cartilage therapy - TheFly
- 10 days ago - FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage - PRNewsWire
- 11 days ago - FibroBiologics price target lowered to $6 from $8 at H.C. Wainwright - TheFly
- 14 days ago - FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate - PRNewsWire
- 15 days ago - FibroBiologics Proxy statement: Proxy filing - Filings
- 15 days ago - FibroBiologics Quarterly report: Q2 2026 - Filings